Jeil Pharma Holdings Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	55,663	59,821	37,039	34,760	28,581	20,183
Short-Term Investments	15,861	16,062	22,092	18,643	18,643	9,778
Cash & Short-Term Investments	71,525	75,883	59,131	53,403	47,224	29,961
Cash Growth	43.93%	28.33%	10.73%	13.08%	57.62%	-0.50%
Accounts Receivable	166,648	188,185	178,437	162,403	149,681	162,013
Other Receivables	5,024	13,437	15,743	15,749	15,305	13,588
Receivables	171,672	201,621	194,180	178,152	164,986	175,601
Inventory	114,051	123,669	125,280	113,266	114,243	124,150
Prepaid Expenses	272.61	257.41	370.95	334.14	210.64	189.94
Other Current Assets	9,344	8,130	5,565	7,762	8,481	5,171
Total Current Assets	366,864	409,561	384,527	352,916	335,144	335,074
Property, Plant & Equipment	243,449	243,942	228,862	233,120	212,965	170,479
Long-Term Investments	110,766	93,756	87,116	83,167	79,022	69,996
Goodwill	-	-	44,862	73,466	151,801	168,815
Other Intangible Assets	9,276	5,384	4,532	3,978	3,781	4,118
Long-Term Accounts Receivable	-0	-0	-0	-0	-0	-0
Long-Term Deferred Tax Assets	7,624	7,630	5,449	188.47	1,452	3,457
Long-Term Deferred Charges	7,032	8,378	8,561	5,494	-	-
Other Long-Term Assets	115,948	121,784	116,087	113,347	108,256	135,456
Total Assets	860,958	890,433	879,997	865,677	892,421	887,395
Accounts Payable	91,927	146,189	154,050	162,967	159,388	149,265
Accrued Expenses	345.17	379.18	289.4	219.46	144.54	170.17
Short-Term Debt	146,906	141,872	195,937	141,247	88,033	130,510
Current Portion of Long-Term Debt	240	-	5,800	3,200	6,125	6,125
Current Portion of Leases	621.82	672.57	707.58	692.18	806.97	574.21
Current Income Taxes Payable	4,010	3,840	774.71	1,160	684.79	4,737
Other Current Liabilities	75,693	85,039	55,077	49,019	42,841	35,937
Total Current Liabilities	319,744	377,991	412,636	358,505	298,024	327,317
Long-Term Debt	16,600	11,900	10,500	16,300	18,531	12,368
Long-Term Leases	590.45	767.2	1,198	1,177	1,576	216.45
Pension & Post-Retirement Benefits	20,592	16,334	10,679	2,727	3,558	9,127
Long-Term Deferred Tax Liabilities	42,707	40,892	37,618	35,755	37,747	31,826
Other Long-Term Liabilities	94.11	5,152	5,180	31,421	32,672	7,256
Total Liabilities	400,328	453,036	477,811	445,885	392,108	388,111
Common Stock	7,987	7,987	7,987	7,987	7,987	7,987
Additional Paid-In Capital	202,017	201,825	176,522	176,058	176,384	173,990
Retained Earnings	33,292	26,146	79,119	98,245	172,151	175,785
Treasury Stock	-3,422	-3,422	-3,422	-3,422	-3,422	-3,422
Comprehensive Income & Other	74,362	74,414	59,256	58,898	58,631	53,112
Total Common Equity	314,236	306,950	319,461	337,765	411,731	407,452
Minority Interest	146,395	130,447	82,725	82,028	88,583	91,832
Shareholders' Equity	460,631	437,397	402,186	419,792	500,314	499,284
Total Liabilities & Equity	860,958	890,433	879,997	865,677	892,421	887,395
Total Debt	164,959	155,212	214,143	162,616	115,072	149,794
Net Cash (Debt)	-93,434	-79,329	-155,012	-109,213	-67,848	-119,832
Net Cash Per Share	-6087.32	-5167.62	-10097.73	-7114.36	-4419.76	-7806.10
Filing Date Shares Outstanding	15.35	15.35	15.35	15.35	15.35	15.35
Total Common Shares Outstanding	15.35	15.35	15.35	15.35	15.35	15.35
Working Capital	47,120	31,570	-28,109	-5,588	37,120	7,757
Book Value Per Share	20469.88	19995.26	20810.28	22002.60	26820.87	26542.15
Tangible Book Value	304,960	301,566	270,066	260,320	256,148	234,519
Tangible Book Value Per Share	19865.64	19644.55	17592.61	16957.74	16685.95	15276.97
Land	120,087	119,324	98,147	98,120	83,677	63,100
Buildings	95,604	142,982	140,779	140,778	137,880	120,479
Machinery	14,772	107,760	107,539	101,172	84,428	79,522
Construction In Progress	-	4,923	3,269	3,851	11,778	7,583

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.